➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Johnson and Johnson
Baxter
Express Scripts
Dow

Last Updated: February 26, 2021

DrugPatentWatch Database Preview

Watson Labs Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for WATSON LABS, and what generic and branded alternatives to WATSON LABS drugs are available?

WATSON LABS has one thousand and thirty-seven approved drugs.

There are eighteen tentative approvals on WATSON LABS drugs.

Summary for Watson Labs
US Patents:0
Tradenames:400
Ingredients:377
NDAs:1037

Drugs and US Patents for Watson Labs

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs BROMPHENIRAMINE MALEATE brompheniramine maleate TABLET;ORAL 083123-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Watson Labs PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE amitriptyline hydrochloride; perphenazine TABLET;ORAL 070376-001 Aug 25, 1986 DISCN No No   Start Trial   Start Trial
Watson Labs Inc AMPICILLIN SODIUM ampicillin sodium INJECTABLE;INJECTION 062816-001 Oct 24, 1988 DISCN No No   Start Trial   Start Trial
Watson Labs Inc SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 202551-001 May 20, 2019 AB RX No No   Start Trial   Start Trial
Watson Labs NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN gramicidin; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OPHTHALMIC 062788-001 Jun 11, 1987 DISCN No No   Start Trial   Start Trial
Watson Labs IBUPROFEN ibuprofen TABLET;ORAL 071905-001 Mar 8, 1988 DISCN No No   Start Trial   Start Trial
Watson Labs SULFAMETHOXAZOLE AND TRIMETHOPRIM sulfamethoxazole; trimethoprim TABLET;ORAL 070000-001 Nov 7, 1984 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Boehringer Ingelheim
McKesson
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.